ES2107659T3 - Complejos ligandos mezclados de aditivos nucleofilos de oxido nitrico empleados como agentes cardiovasculares. - Google Patents

Complejos ligandos mezclados de aditivos nucleofilos de oxido nitrico empleados como agentes cardiovasculares.

Info

Publication number
ES2107659T3
ES2107659T3 ES93908556T ES93908556T ES2107659T3 ES 2107659 T3 ES2107659 T3 ES 2107659T3 ES 93908556 T ES93908556 T ES 93908556T ES 93908556 T ES93908556 T ES 93908556T ES 2107659 T3 ES2107659 T3 ES 2107659T3
Authority
ES
Spain
Prior art keywords
cardiovascular agents
nitle
nucleophil
oxide
additives used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93908556T
Other languages
English (en)
Inventor
Danae D Christodoulou
David A Wink Jr
Larry K Keefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2107659T3 publication Critical patent/ES2107659T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C07F19/005—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00 without metal-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/005—Compounds of elements of Group 5 of the Periodic Table without metal-carbon linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPLEJOS METALICOS DE LIGADO MEZCLADO DE ADUCTOS DE NUCLEOFILOS Y OXIDO NITRICO, UTILES COMO AGENTES CARDIOVASCULARES DE LA FORMULA KA EN LA QUE A ES [(M)X''X(L)Y(R1R2N-N2O2)Z] Y M ES UN METAL FARMACEUTICAMENTE ACEPTABLE, O CUANDO X ES AL MENOS DOS, M PUEDE SER UNA MEZCLA DE DOS METALES DIFERENTES FARMACEUTICAMENTE ACEPTABLES; L ES UN LIGANDO, DISTINTO DE (R1R2N-N2O2) Y ESTA ENLAZADO A AL MENOS UN METAL; R1 Y R2 SON CADA UNO UNIDADES ORGANICAS Y PUEDEN SER IGUALES O DIFERENTES; X ES UN ENTERO DE 1 A 10 INCLUSIVE; X'' ES EL ESTADO DE OXIDACION FORMAL DEL METAL M Y ES UN ENTERO DE 1 A 6 INCLUSIVE; Y ES UN ENTERO DE 1 A 18 INCLUSIVE Y CUANDO Y ES AL MENOS DOS, L PUEDE SER EL MISMO LIGANDO O UNA MEZCLA DE LIGANDOS DIFERENTES; Z ES UN ENTERO DE 1 A 20 INCLUSIVE; SIEMPRE Y CUANDO SI M ES COBRE, X SEA UNO, L SEA METANOL E Y SEA UNO, Y AL MENOS UNO DE ENTRE R1 O R2 NO SEA ETILO; Y K ES UN CONTRAION FARMACEUTICAMENTE ACEPTABLE PRESENTE EN LA COMPOSICION CUANDO LA CARGA TOTAL DE A NO ES CERO, EN DONDEEL CONTRAION K SOLO SE ENCUENTRA PRESENTE EN UNA CANTIDAD QUE NEUTRALICE A. SE PRESENTAN LOS METODOS DE TRATAMIENTO DE MAMIFEROS CON TALES COMPUESTOS. TAMBIEN SE PRESENTAN LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS.
ES93908556T 1992-03-27 1993-03-24 Complejos ligandos mezclados de aditivos nucleofilos de oxido nitrico empleados como agentes cardiovasculares. Expired - Lifetime ES2107659T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/858,885 US5389675A (en) 1992-03-27 1992-03-27 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents

Publications (1)

Publication Number Publication Date
ES2107659T3 true ES2107659T3 (es) 1997-12-01

Family

ID=25329430

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93908556T Expired - Lifetime ES2107659T3 (es) 1992-03-27 1993-03-24 Complejos ligandos mezclados de aditivos nucleofilos de oxido nitrico empleados como agentes cardiovasculares.

Country Status (9)

Country Link
US (1) US5389675A (es)
EP (1) EP0632812B1 (es)
JP (1) JP3637418B2 (es)
AT (1) ATE155475T1 (es)
AU (1) AU661903B2 (es)
CA (1) CA2132847C (es)
DE (1) DE69312276T2 (es)
ES (1) ES2107659T3 (es)
WO (1) WO1993020088A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5814666A (en) * 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US6255277B1 (en) 1993-09-17 2001-07-03 Brigham And Women's Hospital Localized use of nitric oxide-adducts to prevent internal tissue damage
US5631284A (en) * 1993-10-06 1997-05-20 University Of British Columbia Compositions and methods for relaxing smooth muscles
US5840759A (en) * 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
WO1995010267A1 (en) * 1993-10-08 1995-04-20 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
EP0946160A4 (en) * 1996-08-27 2007-05-09 Univ Akron LIPOPHILIC POLYAMINESTER FOR THE SPOT-SPECIFIC DISTRIBUTION OF NITROGEN MONOXIDE IN PHARMACEUTICAL USE
CA2266908C (en) 1996-09-27 2010-07-20 Joseph E. Saavedra O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
US5958427A (en) * 1996-11-08 1999-09-28 Salzman; Andrew L. Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
US6436996B1 (en) * 1997-09-30 2002-08-20 Duke University Modulation of nitric oxide production
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
ITMI20010426A1 (it) * 2001-03-01 2002-09-01 Consiglio Nazionale Ricerche Donatori di ossido di azoto basati su centri metallici
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1436018A1 (en) * 2001-09-26 2004-07-14 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Nitric oxide-releasing coated medical devices and method of preparing same
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
WO2003080039A1 (en) * 2002-03-21 2003-10-02 The University Of Utah Research Foundation In vivo use of glutathionone s-transferase activated nitric oxide donors
JP2005534485A (ja) 2002-08-02 2005-11-17 アメリカ合衆国 架橋した一酸化窒素−放出ポリアミン被覆基質、それを含む組成物及びその製造方法
CA2536827C (en) * 2003-07-09 2014-09-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
JP2007523900A (ja) * 2004-02-09 2007-08-23 ノクシライザー，インコーポレイテッド 一酸化窒素放出分子
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20060039950A1 (en) * 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices
US7968664B2 (en) 2004-09-27 2011-06-28 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
JP2009500083A (ja) * 2005-06-30 2009-01-08 エムシー３， インコーポレイテッド 検体センサーおよびその中で使用するための組成物
WO2007005910A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Nitric oxide coatings for medical devices
WO2007005758A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Methods , compositions and devices for promoting angiogenesis
CA2628055C (en) * 2005-10-31 2013-10-01 Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
EP1968664B1 (en) * 2005-12-02 2010-10-27 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same
EP1968615A4 (en) * 2005-12-06 2010-08-04 Amulet Pharmaceuticals Inc POLYMERS RELEASING NITRIC OXIDE
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
CA2710349A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
CN102014870A (zh) 2008-03-07 2011-04-13 犹他州大学研究基金会 活性的一氧化氮供体及其制备和应用的方法
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3153094A (en) * 1959-06-10 1964-10-13 Du Pont Nitrosamine manufacture
NL145762B (nl) * 1970-05-27 1975-05-15 Sandoz Ag Werkwijze ter bereiding van een farmaceutisch preparaat met hypotensieve/antihypertensieve werking, alsmede gevormd preparaat.
US4954526A (en) * 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
US5039705A (en) * 1989-09-15 1991-08-13 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5155137A (en) * 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines

Also Published As

Publication number Publication date
DE69312276T2 (de) 1998-01-02
AU3933893A (en) 1993-11-08
EP0632812A1 (en) 1995-01-11
JP3637418B2 (ja) 2005-04-13
ATE155475T1 (de) 1997-08-15
CA2132847C (en) 2005-05-24
WO1993020088A1 (en) 1993-10-14
AU661903B2 (en) 1995-08-10
CA2132847A1 (en) 1993-10-14
US5389675A (en) 1995-02-14
JPH08501276A (ja) 1996-02-13
DE69312276D1 (de) 1997-08-21
EP0632812B1 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
ES2107659T3 (es) Complejos ligandos mezclados de aditivos nucleofilos de oxido nitrico empleados como agentes cardiovasculares.
HK1075197A1 (en) New composition containing taxane derivatives as major component
EP0219876A3 (en) Antihypertensive agents comprising 2-alkynyladenosines as active ingredients
IL93556A0 (en) Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
EP0152345A3 (en) Interferon administration vehicles
ES2118835T3 (es) 2-etil-1h-imidazo(4,5-c)quinolin-4-aminas antiviricas.
DE3160905D1 (en) Substituted imidazoles, their preparation and pharmaceutical compositions containing the same
ES362679A1 (es) Un procedimiento para la preparacion de nuevos esteroides anti-inflamatorios, de la serie del pregnano.
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
GB1532993A (en) Injectable antibiotic compositions
IL49835A (en) Preparation of 2,4-dioxo-1,2,3,4tetrahydro-s-triazino-(1,2-a)benzimidazoles, certain such novel compounds and fungicidal compositions containing them
ES8706709A1 (es) Procedimiento de obtencion de complejos de tecnecio.
WO1984004243A3 (fr) Composition de mineraux injectables a usage veterinaire
ATE53039T1 (de) Technetium-aren-komplexe und verfahren.
AU566898B2 (en) Benz (5,6) isoindolo(z,1-b)isoquinoline -8,13-dione and their use as anti-cancer agents
LV10289A (lv) Jauns pentapeptids ta iegusanas panemiens kompozicija sunu augsanas inhibesanai inhibesanas panemiens
GB1507173A (en) Coupling components for dyestuffs
SU1029515A1 (ru) Шихта порошковой проволоки для плазменной наплавки в азотсодержащих газовых смесях и последующего азотирования
ES453237A1 (es) Un procedimiento para la produccion de una preparacion anti-hipertensiva.
GB1478002A (en) Pharmaceutical composition having anti-tumour activity
GB1500054A (en) 5-fluorouracil derivatives and preparation thereof
SU1274290A1 (ru) Антиокислительная присадка к топливам

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 632812

Country of ref document: ES